Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Dura and Spiros update development of Spiros products

Oct. 1, 1998

AxyS Pharmaceuticals discontinues development of APC-366 for asthma

Sep. 30, 1998

Dual LTD4 antagonists/histamine release inhibitors in development at Daiichi

Sep. 30, 1998

LCB-2183 inhibits mast cell activation in vivo in mice

Sep. 29, 1998

Clinical trial results for Ariflo presented at European congress

Sep. 29, 1998

Zeneca's CysLT1 antagonist shows potential for once-daily dosing; efficacy studies warranted

Sep. 29, 1998

V-11294A: an orally active PDE4 inhibitor undergoes testing in healthy volunteers

Sep. 29, 1998

Shionogi describes new PGD2 antagonists for allergic and inflammatory disorders

Sep. 28, 1998

Phase III trials initiated for desloratadine

Sep. 24, 1998

Preclinical studies with YM-26818 indicate efficacy in ARDS, COPD

Sep. 23, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...